IL62267A - Labeled antibodies,compositions containing them and methods for determining the location of a tumor - Google Patents

Labeled antibodies,compositions containing them and methods for determining the location of a tumor

Info

Publication number
IL62267A
IL62267A IL62267A IL6226781A IL62267A IL 62267 A IL62267 A IL 62267A IL 62267 A IL62267 A IL 62267A IL 6226781 A IL6226781 A IL 6226781A IL 62267 A IL62267 A IL 62267A
Authority
IL
Israel
Prior art keywords
tumor
location
determining
methods
compositions containing
Prior art date
Application number
IL62267A
Other languages
English (en)
Other versions
IL62267A0 (en
Original Assignee
Goldenberg Milton David
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27383377&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL62267(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/126,263 external-priority patent/US4331647A/en
Priority claimed from US06/126,262 external-priority patent/US4348376A/en
Priority claimed from US06/126,261 external-priority patent/US4361544A/en
Application filed by Goldenberg Milton David filed Critical Goldenberg Milton David
Publication of IL62267A0 publication Critical patent/IL62267A0/xx
Publication of IL62267A publication Critical patent/IL62267A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Testing Of Coins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Radiation-Therapy Devices (AREA)
  • Nuclear Medicine (AREA)
IL62267A 1980-03-03 1981-03-03 Labeled antibodies,compositions containing them and methods for determining the location of a tumor IL62267A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/126,263 US4331647A (en) 1980-03-03 1980-03-03 Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US06/126,262 US4348376A (en) 1980-03-03 1980-03-03 Tumor localization and therapy with labeled anti-CEA antibody
US06/126,261 US4361544A (en) 1980-03-03 1980-03-03 Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers

Publications (2)

Publication Number Publication Date
IL62267A0 IL62267A0 (en) 1981-05-20
IL62267A true IL62267A (en) 1985-05-31

Family

ID=27383377

Family Applications (1)

Application Number Title Priority Date Filing Date
IL62267A IL62267A (en) 1980-03-03 1981-03-03 Labeled antibodies,compositions containing them and methods for determining the location of a tumor

Country Status (9)

Country Link
EP (1) EP0035265B1 (de)
JP (5) JPH036125B2 (de)
AU (2) AU556548B2 (de)
CA (1) CA1244344A (de)
DE (1) DE3173342D1 (de)
DK (1) DK482181A (de)
IE (1) IE52040B1 (de)
IL (1) IL62267A (de)
WO (1) WO1981002522A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3173342D1 (en) * 1980-03-03 1986-02-13 Milton David Goldenberg Agent for tumor localization and therapy with labeled antibodies and antibody fragments
NO169947C (no) * 1981-10-27 1992-08-26 Hybritech Inc Fremgangsmaate for fremstilling av et monoklonalt antistoff til et tumorassosiert antigen
DE3382317D1 (de) * 1982-03-15 1991-07-25 Schering Corp Hybride dns, damit hergestellte bindungszusammensetzung und verfahren dafuer.
CA1194415A (en) * 1982-05-05 1985-10-01 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
EP0131627B1 (de) * 1983-01-21 1992-05-20 PRIMUS, Frederick James Spezifische antigene der cea(karzyno-embryonales-antigen)familie, spezifische antikörper und verfahren zu ihrer verwendung
AU577781B2 (en) * 1983-04-28 1988-10-06 Mark Philip Best Lung imaging with radiolabelled agents
CA1242643A (en) * 1983-08-12 1988-10-04 Eric T. Fossel Nmr imaging utilizing chemical shift reagents
JPS60201260A (ja) * 1984-03-27 1985-10-11 Yamasa Shoyu Co Ltd 心疾患診断薬
US4837003A (en) * 1984-09-13 1989-06-06 Mallinckrodt, Inc. Radiolabeled antibody fragments
US4824659A (en) * 1985-06-07 1989-04-25 Immunomedics, Inc. Antibody conjugates
US5776093A (en) 1985-07-05 1998-07-07 Immunomedics, Inc. Method for imaging and treating organs and tissues
US4735210A (en) * 1985-07-05 1988-04-05 Immunomedics, Inc. Lymphographic and organ imaging method and kit
EP0221653A3 (de) * 1985-09-20 1989-02-15 The Regents Of The University Of California Verfahren zur doppelisotop-farbfunktionellen Erfassung mittels radiomarkierter monoklonaler Antikörper, Reagenzsätze dafür und Antikörper zur Verwendung in diesem Verfahren
GB8525974D0 (en) * 1985-10-22 1985-11-27 Nyegaard & Co As Chemical substance
FR2604092B1 (fr) * 1986-09-19 1990-04-13 Immunotech Sa Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo
US5164175A (en) * 1986-12-10 1992-11-17 Hoechst Aktiengesellschaft Diagnostic aid containing an organ-specific substance labeled with technetium-99m
US4867962A (en) * 1988-02-26 1989-09-19 Neorx Corporation Functionally specific antibodies
CA1339415C (en) * 1989-08-24 1997-09-02 Milton David Goldenberg Detection and treatment of infections with immunoconjugates
CA2086531A1 (en) * 1990-07-03 1992-01-04 Ebo S. Bos Immunoreactive compound
GB9115192D0 (en) * 1991-07-12 1991-08-28 Antisoma Ltd Cancer treatment
KR19980038203A (ko) * 1996-11-25 1998-08-05 규오 리 헤 항-간암 마우스 모노클로날 항체에 의해 전달되는 방사성소핵체를 함유하는 의약
BRPI0717395A2 (pt) * 2006-10-25 2013-10-15 Koninkl Philips Electronics Nv Composto para diagnosticar câncer de próstata em um indivíduo humano ou animal, composição farmacêutica, e, uso de um composto ou uma composição

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960827A (en) * 1972-07-10 1976-06-01 Bjoerklund K B Cancer associated polypeptide antigen, process for its preparation, process for preparing antibodies, process of cancer diagnosis and composition useful as an immunizing agent
US4211766A (en) * 1972-07-10 1980-07-08 Ab Bonnierforetagen Cancer associated polypeptide antigen compositions
US3927193A (en) * 1973-05-18 1975-12-16 Hoffmann La Roche Localization of tumors by radiolabelled antibodies
US4160018A (en) * 1973-06-25 1979-07-03 Bjorklund Knut B Stabilized cancer associated polypeptide antigen and preparation thereof
DE2643208C2 (de) * 1976-09-25 1985-09-05 Behringwerke Ag, 3550 Marburg Immunologisches Bestimmungsverfahren
US4160817A (en) * 1976-09-29 1979-07-10 Research Corporation Application of protein-protein interaction as an assay for the detection of cancer
US4174385A (en) * 1976-10-08 1979-11-13 Robert Reid Method of identification of surface proteins of cancer cells, clinical test and method of immunization
US4146603A (en) * 1977-02-18 1979-03-27 Research Corporation Tumor specific glycoproteins and method for detecting tumorigenic cancers
US4234561A (en) * 1978-02-06 1980-11-18 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
ZA792457B (en) * 1978-05-22 1981-05-27 Serono Lab Method and composition for cancer detection in humans
AU529951B2 (en) * 1979-10-22 1983-06-30 Samuel Bogoch Detection of malignant tumour cells
DE3173342D1 (en) * 1980-03-03 1986-02-13 Milton David Goldenberg Agent for tumor localization and therapy with labeled antibodies and antibody fragments

Also Published As

Publication number Publication date
JPH03141230A (ja) 1991-06-17
EP0035265A2 (de) 1981-09-09
EP0035265A3 (en) 1982-04-07
AU7034181A (en) 1981-09-23
CA1244344A (en) 1988-11-08
AU556548B2 (en) 1986-11-06
JPH0684315B2 (ja) 1994-10-26
WO1981002522A1 (en) 1981-09-17
EP0035265B1 (de) 1986-01-02
JPH03141231A (ja) 1991-06-17
JPH0684313B2 (ja) 1994-10-26
AU6786887A (en) 1987-04-30
DK482181A (da) 1981-11-02
JPH0720887B2 (ja) 1995-03-08
AU581555B2 (en) 1989-02-23
JPH036125B2 (de) 1991-01-29
DE3173342D1 (en) 1986-02-13
JPH03157337A (ja) 1991-07-05
IE52040B1 (en) 1987-05-27
JPH03157338A (ja) 1991-07-05
JPH0684314B2 (ja) 1994-10-26
IL62267A0 (en) 1981-05-20
JPS57500195A (de) 1982-02-04
IE810451L (en) 1981-09-03

Similar Documents

Publication Publication Date Title
GB2086041B (en) Immunassay utilising monoclonal antibodies
IL62267A (en) Labeled antibodies,compositions containing them and methods for determining the location of a tumor
JPS5786051A (en) Determination of antigen employing two or more monochronal antibodies
GB8332646D0 (en) Antibodies
IL62811A0 (en) Assaying methods involving biospecific affinity reactions
DE3163764D1 (en) Method and reagent for the determination of antithrombin-bm
DE3067906D1 (en) Method for the preparation of bis-styrylbenzenes
GB2083836B (en) Monoclonal antibody
GB8316001D0 (en) Monoclonal antibodies
JPS57196154A (en) Monochronal antibody
DE3162467D1 (en) Method for the preparation of aldehydes
GB2092644B (en) Tunnel linings
DE3162511D1 (en) Method for the preparation of amino-nitriles
GB8330331D0 (en) Monoclonal antibody
GB8504271D0 (en) Monoclonal antibody
IL67295A0 (en) Monoclonal antibodies against leishmania
JPS57118160A (en) Single test composition for immuno-assay
JPS5713396A (en) Lining container
KE3716A (en) Method for the quantitative determination of encainide
JPS56167497A (en) Bond
AU7035781A (en) Monoclonal antibodies
PL231041A1 (en) Propping-encasing lining
SG30587G (en) Method for the quantitative determination of encainide
BG34154A1 (en) Method for quantitative determining of the chlorcholinechloride
AU535676B2 (en) Method for the determination of antigens, antibodies and their complexes

Legal Events

Date Code Title Description
KB Patent renewed
EXP Patent expired